A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry

ABSTRACT Ebola virus (EBOV) causes highly lethal disease outbreaks against which no FDA-approved countermeasures are available. Although many host factors exploited by EBOV for cell entry have been identified, including host cell surface phosphatidylserine receptors, endosomal cysteine proteases, an...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: J. Maximilian Fels, Jennifer S. Spence, Robert H. Bortz, Zachary A. Bornholdt, Kartik Chandran
Format: article
Langue:EN
Publié: American Society for Microbiology 2019
Sujets:
Accès en ligne:https://doaj.org/article/20567a5fc6a94a1da98fb64f9492e78d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!